Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
11/23/2010 | US7838289 Assay utilizing multipotent adult stem cells |
11/23/2010 | US7838041 autologously transplanting hematopoietic progenitor cell population which has been treated with antibody (monoclonal, chimeric, or humanized; not conjugated to toxin or cytolytic agent); radiotherapy |
11/23/2010 | CA2461068C Cell populations which co-express cd49c and cd90 |
11/23/2010 | CA2459380C Reverse hydroxamic acid derivatives |
11/23/2010 | CA2438870C Novel inhibitors of formation of advanced glycation endproducts (ages) |
11/23/2010 | CA2377309C Compounds for the modulation of ppar.gamma. activity |
11/23/2010 | CA2373302C Conditioned cell culture medium compositions and methods of use |
11/21/2010 | CA2671921A1 Inclusion complex of raloxifene hydrochloride and .beta.-cyclodextrin |
11/18/2010 | WO2010132389A2 Methods for treating cancers and diseases associated with 4-1bb (cd137) expression |
11/18/2010 | WO2010131922A2 Amide compound, preparation method thereof and pharmaceutical composition comprising same |
11/18/2010 | WO2010131738A1 Azetidine compound and medicinal use thereof |
11/18/2010 | WO2010131703A1 NOVEL PPARγ PROMOTER SEQUENCE AND USE APPLICATION THEREOF |
11/18/2010 | WO2010131185A1 Blocking anti-dkk-1 antibodies and their uses |
11/18/2010 | WO2010130466A1 Sulphated hyaluronic acids as regulator agents of the cytokine activity |
11/18/2010 | WO2010102824A3 Sodium salt of 5-cyclopropyl-2-{[2-(2,6- difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as dhodh inhibitor |
11/18/2010 | WO2010078466A3 Sand fly salivary proteins with anti-complement activity and methods of their use |
11/18/2010 | WO2010075423A3 Dendrimer based modular platforms |
11/18/2010 | WO2010071866A3 Combination therapy for arthritis with tranilast |
11/18/2010 | US20100292791 Fully synthetic implantable multi-phased scaffold |
11/18/2010 | US20100292345 Therapeutic uses of cannabigerol |
11/18/2010 | US20100292296 Novel ligands that modulate rar receptors |
11/18/2010 | US20100292295 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators |
11/18/2010 | US20100292279 Bis-(Sulfonylamino) Derivatives in Therapy |
11/18/2010 | US20100292254 Fused Pyrimidine Derivatives as Trpv3 Modulators |
11/18/2010 | US20100292252 Vinyl-aryl derivatives for inflammation and immune-related uses |
11/18/2010 | US20100292243 7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF |
11/18/2010 | US20100292235 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof |
11/18/2010 | US20100292234 Triazole fused heteroaryl compounds and methods of use thereof |
11/18/2010 | US20100292229 Tryphostin-analogs for the treatment of cell proliferative diseases |
11/18/2010 | US20100292213 Anti-Inflammatory Agents |
11/18/2010 | US20100292208 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase |
11/18/2010 | US20100292197 Compositions and Methods for Increasing Telomerase Activity |
11/18/2010 | US20100292196 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
11/18/2010 | US20100292194 Formulas comprising highly soluble elements and vitamins for the prevention and amelioration of osteoporosis |
11/18/2010 | US20100292159 Method of treatment or prophylaxis of inflammatory pain |
11/18/2010 | US20100292156 Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof |
11/18/2010 | US20100292155 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
11/18/2010 | US20100292154 Protein profile for osteoarthritis |
11/18/2010 | US20100292151 Use of human cytokine receptor |
11/18/2010 | US20100292150 Treatment of Menorrhagia with Aromatase Inhibitor |
11/18/2010 | US20100292148 Targeted polylysine dendrimer therapeutic agent |
11/18/2010 | US20100292146 Composite bone repair material |
11/18/2010 | US20100291240 Method to Stabilize a Dietary Supplement to Facilitate Joint Health in Humans |
11/18/2010 | US20100291234 Compositions and methods for treating inflammatory arthritis |
11/18/2010 | US20100291220 Antibiotic formulation and method of treatment |
11/18/2010 | US20100291215 Drug delivery matrices to enhance wound healing |
11/18/2010 | US20100291212 Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use |
11/18/2010 | US20100291209 Organic compounds |
11/18/2010 | US20100291206 Oral dosage form |
11/18/2010 | US20100291185 Theritol phosphates, salts thereof and methods of use |
11/18/2010 | US20100291182 Drug-Loaded Fibers |
11/18/2010 | US20100291171 Hyaluronic acid derivatives obtained via "click chemistry" crosslinking |
11/18/2010 | US20100291160 Pharmaceutical system for trans-membrane delivery |
11/18/2010 | US20100291117 Method for ex-vivo expansion of regulatory t cells with enhanced suppressive function for clinical application in immune mediated diseases |
11/18/2010 | US20100291076 Antibodies specific for dkk-1 and their uses |
11/18/2010 | US20100291053 Inflammatory Disease Treatment |
11/18/2010 | US20100291028 Use of il-18 inhibitors for treatment and/or prevention of peripheral vascular diseases |
11/18/2010 | US20100291026 Piperidine inhibitors of janus kinase 3 |
11/18/2010 | US20100291020 Novel compounds as dipeptidyl peptidase iv (dpp iv) inhibitors |
11/18/2010 | US20100291001 Metalloproteinase-binding proteins |
11/18/2010 | US20100290993 Antibodies to IL-6 and use thereof |
11/18/2010 | CA2761696A1 Blocking anti-dkk-1 antibodies and their uses |
11/18/2010 | CA2761627A1 Sulphated hyaluronic acids as regulator agents of the cytokine activity |
11/17/2010 | EP2251339A2 Compounds |
11/17/2010 | EP2251338A2 Organic compounds |
11/17/2010 | EP2251024A1 Plant-origin drug for preventing or improving hyperuricemia |
11/17/2010 | EP2249832A1 Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds |
11/17/2010 | EP2249820A1 Trpa1 antagonists |
11/17/2010 | CN1935248B Chinese medicine preparation for treating lumbar-cervical vertebra disease |
11/17/2010 | CN101889009A Inhibitors of c-fms kinase |
11/17/2010 | CN101886123A Application of vascular endothelial growth factor receptor-2 (VEGFR-2) in temporomandibular joint disturbance |
11/17/2010 | CN101886106A Method for extracting collagen peptide from fish scales |
11/17/2010 | CN101885770A Fully human antibody capable of specifically bonding CD15 and use thereof |
11/17/2010 | CN101885769A Fully human antibody capable of specifically bonding CD4 and use thereof |
11/17/2010 | CN101885731A Thiophene derivative |
11/17/2010 | CN101885718A Iguratimod crystal habit and composition thereof |
11/17/2010 | CN101885717A Iguratimod crystal habit and composition thereof |
11/17/2010 | CN101884811A Bone grafting material of gradient porous beta-TCP with bioactivity and anti-infection effect, preparation method and application thereof |
11/17/2010 | CN101884790A Medicament for treating cervical ossified posterior longitudinal ligament |
11/17/2010 | CN101884777A Chinese medicinal iron applying bag for treating rheumatic osteoarthrosis and preparation method thereof |
11/17/2010 | CN101884765A Medicament for treating big belly known as beer belly |
11/17/2010 | CN101884756A Pharmaceutical composition with functions of expelling wind and removing dampness and activating collaterals and relieving pain, preparation method, preparation and application thereof |
11/17/2010 | CN101884752A Chinese medicinal preparation for navel plaster and preparation method thereof |
11/17/2010 | CN101884749A Particle for eliminating turbidity and treating arthralgia |
11/17/2010 | CN101884716A Medicinal liquor for treating lumbar disc herniation |
11/17/2010 | CN101884711A Traditional Chinese medicine for treating scapulohumeral periarthritis and protrusion of lumbar vertebral disc |
11/17/2010 | CN101884705A Chinese medicinal preparation for treating protrasion of the lumbar intervertebral disci |
11/17/2010 | CN101884702A Joint adhesion treatment ointment |
11/17/2010 | CN101884665A Traditional Chinese medicine extract with alpha-glucuroide and xanthine oxidase inhibiting effect and preparation method and usage thereof |
11/17/2010 | CN101884664A Medicinal composition for preventing and treating rheumatoid arthritis and preparation method thereof |
11/17/2010 | CN101884658A Compound angelica medicament injection preparation containing polyethylene glycol 12-hydroxystearate and preparation method thereof |
11/17/2010 | CN101884653A Chinese medicinal preparation for treating rheumatoid arthritis |
11/17/2010 | CN101884652A Medicament for treating osteoproliferation |
11/17/2010 | CN101450032B Rose whitening moisture-retention gel and preparation method thereof |
11/17/2010 | CN101391050B Traditional Chinese medicine capsule for treating cervical-shoulder disease |
11/17/2010 | CN101234150B Pharmaceutical composition for foaming elimination poison and promoting menstruation and dissipating mass and preparation thereof |
11/17/2010 | CN101199815B Medicament compound for treating rheumatism, rheumatoid arthritis |
11/17/2010 | CN101181389B Medicine for treating rheumatoid arthritis |
11/17/2010 | CN101168023B Plaster for treating protrusion of lumbar intervertebral disk |
11/17/2010 | CN101129675B Externally used plaster for treating rheumatism and kind of rheumatism |